Factors Influencing the Production of Recombinant SV40 Vectors
Open Access
- 31 October 2004
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 10 (4) , 780-791
- https://doi.org/10.1016/j.ymthe.2004.06.1014
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Simian Virus 40 Infection of HumansJournal of Virology, 2003
- HIV-1 proprotein processing as a target for gene therapyGene Therapy, 2003
- T Antigens of Simian Virus 40: Molecular Chaperones for Viral Replication and TumorigenesisMicrobiology and Molecular Biology Reviews, 2002
- Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4Gene Therapy, 2001
- Gene therapy using SV40-derived vectors: What does the future hold?Journal of Cellular Physiology, 1999
- Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selectionGene Therapy, 1999
- Influenza virus naked RNA can be expressed upon transfection into cells co-expressing the three subunits of the polymerase and the nucleoprotein from simian virus 40 recombinant virusesJournal of General Virology, 1993
- Helpers for efficient encapsidation of SV40 pseudovirionsGene, 1989
- Random integration of SV40 in SV40-transformed, immortalized human fibroblastsExperimental Cell Research, 1987
- Integration and excision of SV40 DNA from the chromosome of a transformed cellCell, 1980